Skip to content

Application of Medicinal and Edible Wumei-Honeysuckle Tea Spray in Maintenance Hemodialysis Patients with Thirst

Application of Medicinal and Edible Wumei-Honeysuckle Tea Spray in Maintenance Hemodialysis Patients with Thirst

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122813
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Renal Disease

Interventions

Trial Group:Herbal Plum and Chrysanthemum Tea Spray (Room Temperature), Nurse-administered, sprayed three times per site before machine operation, 2 hours after machine operation, and after machine re
Control Group:Herbal Plum and Chrysanthemum Tea Spray (4–6°C), Nurse-administered, sprayed three times per site before machine operation, 2 hours after machine operation, and after machine removal, wi
Blank Group:Distilled Water Spray, Nurse-administered, sprayed three times per site before machine operation, 2 hours after machine operation, and after machine removal, with each spray delivering 0.1

Sponsors

Zhangzhou Municipal Hospital, Fujian Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-75 years old; 2. Dialysis duration >=3 months; Three times a week, four hours each time; 3. Patients with a visual scale analysis score of >=5 points; 4. Patients who are conscious, in stable condition and capable of communication; 5. Informed consent and voluntary acceptance of intervention.

Exclusion criteria

Exclusion criteria: 1. Patients with oral discomfort; 2. For patients who cannot tolerate Prunus mume/honeysuckle; 3. Those with poor control of blood sugar and blood pressure; 4. Patients with a history of xerostomia; 5. Patients with a history of major diseases within the past three months.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) Score;Lip, Tongue and Oral Mucosa Moisture Score;Unstimulated Whole Saliva Flow Rate (UWS);Interdialytic Weight Gain (IDWG);Ultrafiltration Volume;Mean Arterial Pressure (MAP);Incidence of Adverse Events;

Countries

China

Contacts

Public ContactChen Yase

Zhangzhou Municipal Hospital, Fujian Province

876192394@qq.com+86 150 0600 9371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026